Merck Announces Health Canada Approval of ENFLONSIA® for the prevention of RSV in newborns and infants
KIRKLAND, QC – Merck , known as MSD outside the United States and Canada, announced that Health Canada has approved ENFLONSIA® (clesrovimab) for the prevention of respiratory syncytial virus (RSV) lower… Read More




